CDRH Staff, Panelists Perplexed By Diathermy Effect On Pacemaker Leads
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Surveillance & Biometrics is examining whether the dangers of diathermy therapy's interaction with deep-brain stimulation leads may extend to pacemakers
You may also be interested in...
Diathermy Interactions With Implanted Leads Cited In CDRH Health Notice
Shortwave and microwave diathermy is contra-indicated in patients with implanted metallic leads, the Center for Devices & Radiological Health is warning
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.